Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kan Biosys is a leading Indian agri-biotech company that specializes in developing microbial solutions for sustainable agriculture and soil health. The company focuses on the research and manufacturing of bio-fertilizers, bio-pesticides, and soil conditioners that utilize beneficial microorganisms to enhance crop productivity. Their flagship product, Speed Kompost, provides an innovative solution for in-situ crop residue management, helping to mitigate the environmental impact of stubble burning. By integrating advanced fermentation technologies with ecological science, Kan Biosys offers biological alternatives that reduce the agricultural sector's reliance on chemical inputs. The company serves a global market, promoting regenerative farming practices and long-term soil sustainability. Their portfolio includes a wide range of microbial strains tailored for nitrogen fixation, phosphate solubilization, and pest control. Kan Biosys is recognized for its commitment to carbon sequestration and improving the carbon footprint of modern farming.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kan Biosys.